Evidence map›Paper›PMID 32714331›Full record

ReviewFrontiers in immunology2020

Current Insights in Cutaneous Lupus Erythematosus Immunopathogenesis.

Colton J Garelli, Maggi Ahmed Refat, Padma P Nanaware, Zaida G Ramirez-Ortiz, Mehdi Rashighi, Jillian M Richmond

Open access · goldAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Frontiers in immunology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed, 1 pooled it
2.3field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 1 synthesis or guideline pooled it, 51 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Review
  5. Article
  6. Evolving role of CD8Frontiers in immunology · 2026
    Review
  7. Review
  8. [Lupus erythematosus].Dermatologie (Heidelberg, Germany) · 2025
    Review
  9. Cellular therapies in rheumatic and musculoskeletal diseases.Journal of translational autoimmunity · 2025
    Review
  10. Review
  11. Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Colton J GarelliDepartment of Dermatology, University of Massachusetts Medical School, Worcester, MA, United States.
Maggi Ahmed RefatDepartment of Dermatology, University of Massachusetts Medical School, Worcester, MA, United States.
Padma P NanawareDepartment of Pathology, University of Massachusetts Medical School, Worcester, MA, United States.
Zaida G Ramirez-OrtizDepartment of Medicine, University of Massachusetts Medical School, Worcester, MA, United States.
Mehdi RashighiDepartment of Dermatology, University of Massachusetts Medical School, Worcester, MA, United States.
Jillian M RichmondDepartment of Dermatology, University of Massachusetts Medical School, Worcester, MA, United States.
University of Massachusetts Chan Medical School · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cutaneous Lupus Erythematosus (CLE) is a clinically diverse group of autoimmune skin diseases with shared histological features of interface dermatitis and autoantibodies deposited at the dermal-epidermal junction. Various genetic and environmental triggers of CLE promote infiltration of T cells, B cells, neutrophils, antigen presenting cells, and NK cells into lesional skin. In this mini-review, we will discuss the clinical features of CLE, insights into CLE immunopathogenesis, and novel treatment approaches.

Indexed as

HumansLupus Erythematosus, CutaneousautoantibodiesautoimmuneCLEcutaneousinterface dermatitislupuslupus bandUV light

Identifiers

PMID32714331
PMCPMC7343764
OpenAlexW3040445112

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.